Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

PLoS ONE

Topics

Biology

Immunology

Computer Science

Mathematics

Medicine

Show all topics

DOI

10.1371/journal.pone.0210041

License

CC-BY

Other Formats

PDF